Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Artery Infusion (HAI) Program at Duke University

NCT04511793 is registered in ClinicalTrials.gov with Michael Lidsky, M.D. as lead sponsor.

NCT NCT04511793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04511793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Artery Infusion (HAI) Program at Duke University
Lead sponsor
Michael Lidsky, M.D.
Phase
Not applicable
Overall status
Withdrawn
Start date
December 11, 2020
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholangiocarcinoma, liver cancer, metastatic colon cancer